Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 4

DTI-MRI findings in synthetic cannabinoid users

Pages
1022–1027
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

DTI is a useful tool toreveal WM changes in SC addicts and can be used earlier than conventional MRI.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Synthetic cannabinoids (SCs) are full agonists of both cannabinoid receptors.
📊
Key Findings & Data:Conventional magnetic resonanceimaging (MRI) findings of SC users are mainly defined as diffusion restriction and T2/FLAIR hyperintensity.
💡
Conclusion & Impact:DTI is a useful tool toreveal WM changes in SC addicts and can be used earlier than conventional MRI.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Synthetic cannabinoids (SCs) are full agonists of both cannabinoid receptors. Conventional magnetic resonanceimaging (MRI) findings of SC users are mainly defined as diffusion restriction and T2/FLAIR hyperintensity. Diffusion tensor imaging(DTI) studies examining SC users have shown contradictory results. The aim of this study was to define white matter (WM) changes ofSC users using DTI.Materials and methods: The study included 22 patients with a history of using SC for 5–37 months, and 22 healthy, age and sexmatched control subjects. A total of 41 diffusion gradient directions were used in the acquisition of diffusion imaging data. Fractionalanisotropy (FA) and apparent diffusion coefficients (ADC) values were obtained. ROIs were placed on WM areas of normal appearance.Results: In the SC users, significantly lower FA values were determined in the left temporal lobe (216.2 ± 58.9 vs. 263 ± 27.4; P =0.002) and right hippocampus (224.5 ± 61.5 vs. 255 ± 24.3; P = 0.040). The ADC values of the hippocampus and temporal lobe weresignificantly higher than those of the control group on both the left and right sides.Conclusion: The SC use causes WM microstructural changes, especially in the hippocampus and temporal lobes. DTI is a useful tool toreveal WM changes in SC addicts and can be used earlier than conventional MRI.

🔖

Cite This Article

GÖKHARMAN, D., KOŞAR, P. N., AYDIN, S., PALTUN, S., ŞAHİNER, Ş., FATİHOĞLU, E. (2022). DTI-MRI findings in synthetic cannabinoid users. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 4, 1022–1027. https://ajindex.com/articles/609640

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Barratt MJ, Cakic V, Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review 2013
  2. 32 (2): 141- 146. doi: 10.1111/j.1465-3362.2012.00519.x 2. Spaderna M, Addy PH, D’Souza DC. Spicing things up: synthetic cannabinoids. Psychopharmacology 2013
  3. 228 (4): 525-540. doi: 10.1007/s00213-013-3188-4 3. Wolff V, Lauer V, Rouyer O, Sellal F, Meyer N et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients. Stroke 2011
  4. 42 (6): 1778-1780. doi: 10.1161/STROKEAHA.110.610915 4. Kak M, Mikhail F, Yano ST, Guan R, Lukas RV. Buzz juice: neurological sequelae of synthetic cannabinoids. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 2017
  5. doi: 10.1016/j. jocn.2016.10.046 5. Zorlu N, Di Biase MA, Kalaycı ÇÇ, Zalesky A, Bağcı B et al. Abnormal white matter integrity in synthetic cannabinoid users. European Neuropsychopharmacology 2016
  6. 26 (11): 1818-1825. doi: 10.1016/j.euroneuro.2016.08.015 6. Kubicki M, Westin CF, Maier SE, Mamata H, Frumin M et al. Diffusion tensor imaging and its application to neuropsychiatric disorders. Harvard Review of Psychiatry 2002
  7. 10 (6): 324-336. doi: 10.1080/10673220216231 7. Delisi LE, Bertisch HC, Szulc KU, Majcher M, Brown K et al. A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduction Journal 2006
  8. doi: 10.1186/1477-7517-3-17 8. Filbey FM, Aslan S, Calhoun VD, Spence JS, Damaraju E et al. Long-term effects of marijuana use on the brain. Proceedings of the National Academy of Sciences of the United States of America 2014
  9. 111 (47): 16913-16918. doi: 10.1073/ pnas.1415297111 9. Gruber SA, Dahlgren MK, Sagar KA, Gonenc A, Lukas SE. Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity. Psychopharmacology 2014
  10. 231 (8): 1455-1465. doi: 10.1007/s00213-013-3326-z 10. Yucel M, Zalesky A, Takagi MJ, Bora E, Fornito A et al. Whitematter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study. Journal of Psychiatry & Neuroscience: JPN 2010
  11. 35 (6): 409-412. doi: 10.1503/jpn.090177 11. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 2005
  12. 53 (4): 695-699. doi: 10.1111